Disclaimer: This is a user generated content submitted by a member of the WriteUpCafe Community. The views and writings here reflect that of the author and not of WriteUpCafe. If you have any complaints regarding this post kindly report it to us.

Recruiting clinical trial participants is hugely influential for the entirety of your drug trial. Entering the recruitment phase of any trial might seem straightforward on paper, but the reality can be very different. The recruitment process can directly impact your trial timeline, as well as the proposed budget of the trial. It influences the tools and resources required to complete the trial and, ultimately, the results of the trial. When you’re conducting research on new pharmaceutical drugs, the integrity of the data is paramount. When deciding on the details for your trial and which Phase 1 clinical trial units to use recruitment strategies that will maintain your timeline, budget, and more, are essential considerations. Here’s what those strategies can look like.

Establish a Clear Picture of Potential Participants

When recruiting participants, numerous variables need to be addressed ahead of the clinical trial and ahead of the recruitment process itself. Your ideal candidate must be clearly defined. What should the participant pool look like for your trial? This means considering variables like age, gender, ethnicity, and health status. Are there specifics categories that will be required for your study? The trial may call for an age group between 55 and 72, male and female, but there may be other variables to consider, as well. If you are recruiting for women aged 55 to 72, should they be post-menopausal? What about their osteoarthritic status? The more clearly you can define the essential factors for your potential participants, the more streamlined the recruitment process can be.

The Structure of the Clinic Trial Matters

The way a trial is structured can directly impact your recruitment process. This is a detail that can be overlooked. For example, a study with a short confinement period with a shorter follow-up period may garner a high level of participant attention. It’s straightforward, the participants get the agreed-upon stipend, and the process ends. A study with a longer period of confinement with a longer follow-up period can be more challenging to recruit for due to the more intensive commitment on the part of the participant. To overcome the challenge, the full time of the trial and the budget may need to be expanded. This expansion allows for an increase in advertising for the trial (thus reaching more potential participants) and compensation for participants.

Understand the True Cost of Stipends

From early clinical development to Phase 1 trials and beyond, participant stipends can play a important role in the success of your recruitment process. In many cases, potential participants have grown to expect stipends that match their level of involvement. Naturally, shorter or less-involved trials can be paired with a smaller stipend budget. In developing a stipend budget, you should consider several factors, including the length and involvement of participants. However, there are additional factors to keep in mind as well, such as inpatient versus outpatient visits, dosing visits versus non-dosing visits, and more involved visits or stays for participants. More time and effort required by a participant must be met with a stipend that makes sense—for both the participants and the trial sponsor.

About Altasciences

Are you looking for a drug development partner? Altasciences, a mid-sized contract research organization, is the partner with the expertise you need to make your next project a success. As an integrated CRO with pharmaceutical CDMO services, Altasciences offers partners more than 25 years of research experience for preclinical studies and clinical trials. This CRO/CDMO uses an innovative, integrated approach that pharmaceutical and biotechnology companies can rely on. Altasciences also offers partners expertise in a wide range of study types and therapeutic indications. This includes a wealth of experience in first-in-human clinical trials and CNS clinical trials. Partners also gain access to essential resources, including experienced and highly trained staff, a recruiting database of over 400,000 potential participants, and over 580 beds for overnight studies. Choose this trusted CRO/CDMO for all your early clinical development needs.

Learn more about strengthening your clinical trial recruitment at https://www.altasciences.com/

Original Source: https://bit.ly/3srGvod

Do you like Altasciences's articles? Follow on social!


Welcome to WriteUpCafe Community

Join our community to engage with fellow bloggers and increase the visibility of your blog.
Join WriteUpCafe